Evidence map›Paper›PMID 39377503›Full record

SynthesisPathologica2024

Histopathological lesions of the gastrointestinal tract associated with the use of polystyrene sulfonate and sevelamer: a meta-analysis.

Gianluca Di Rienzo, Pellegrino Crafa, Marco Delsante, Enrico Fiaccadori, Giuseppe Pedrazzi, Nicoletta Campanini, Emilia Corradini

Abstract readMeta-Analysis
In one paragraph

Synthesis in Pathologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gianluca Di RienzoDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Pellegrino CrafaDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Marco DelsanteDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Enrico FiaccadoriDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Giuseppe PedrazziDepartment of Neuroscience, Biophysics and Medical Physics Unit, University of Parma, Parma, Italy.
Nicoletta CampaniniDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Emilia CorradiniDepartment of Medicine and Surgery, University of Parma, Parma, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastrointestinal severe adverse events such as ulceration and perforation have been reported for sodium or calcium polystyrene sulfonate and sevelamer. Howewer, their role in the pathogenesis is unclear. Chronic kidney disease is a well known risk factor, while the role of hypertension and/or diabetes is uncertain. Methods: A meta-analysis of the published literature was conducted to review the clinical features, risk factors and histopathological findings of patients who experienced gastrointestinal adverse events after administration of polystyrene sulfonate or sevelamer. Results: The meta-analysis indicated that patients were more likely to show necrosis and/or perforation when the resin used was polystyrene sulfonate compared to sevelamer (p Discussion: The results show that sevelamer is more likely to lead to inflammation or ulceration in the gastrointestinal tract than polystyrene sulfonate, which is more likely to be associated with severe gastrointestinal adverse events such as necrosis and/or perforation. Polystyrene sulfonate is significantly associated with death compared to sevelamer.

Indexed as

Chelating AgentsGastrointestinal DiseasesGastrointestinal TractPolystyrenesSevelamerHumansNecrosisRenal DialysisRenal Insufficiency, ChronicRisk FactorsChelating AgentsPolystyrenespolystyrene sulfonic acidSevelamergastrointestinal adverse eventspolystyrene sulfonatesevelamer

Identifiers

PMID39377503
PMCPMC11460155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.